HOSPITAL ADMINISTRATION MANAGEMENT

Dear students get fully solved assignments

Send your semester & Specialization name to our mail id :

help.mbaassignments@gmail.com

or

call us at : 08263069601

AEREN FOUNDATION’S                                                                              Maharashtra Govt. Reg. No.: F-11724

 

Case Study Project

Total Marks: 100

SUBJECT - HOSPITAL ADMINISTRATION MANAGEMENT

N. B.: 1)Attempt any Four Questions

2)All questions carries equal marks.

Case Study 1

-- A New Approach to Managing GORD - ALTANA Pharma

ISSUES TO BE DISCUSSED

Q. 1. Discuss the salient features put up in the case.

Answer:Within the framework of its research and development efforts, ALTANA invests in generating knowledge. This results, for example, in inventions that ALTANA protects with patents as intellectual property. But this does not earn the company money. On the contrary, research initially means spending money to generate knowledge.

Unlike a discovery or an invention, however, an innovation is marked by the fact that the knowledge generated creates value or benefits for our customers and for ALTANA. With the innovation, therefore, knowledge is converted into value or benefits.

Q. 2. Evaluate the new approach based on your understanding of the case.

Answer: A new method has been developed for diagnosing gastro-oesophageal reflux disease and assessing treatment progress.

Until now, assessing the progress of treatment for Gastro-Oesaphageal Reflux Disease (GORD) has relied primarily on an assessment of oesophageal healing. Documenting GORD therapy success is a difficult task, as mucosal damage does not always correspond with the severity of symptoms.1 In addition, 70% of all patients with GORD symptoms have endoscopic-negative GORD.

Q. 3. The case indicates two research studies. Give your insights based on these two studies.

Answer:As a focused specialty chemicals company, ALTANA offers its customers highly specialized technological solutions in niche markets. Due to this business model, innovation is an important element of the company’s corporate strategy, ensuring that ALTANA will keep growing in the long term and remain the technology and market leader. ALTANA is therefore a research-intensive company, which is reflected by the fact that 5 - 6 % of its sales are invested in research and development – around twice as much as the industry

Case -2

A New Concept in Annuloplasty for Valve Repair: the Biodegradable Ring - BIORING

ISSUES TO BE DISCUSSED

Q. 1. Bring out the facts as enumerated in the case.

Answer:The Kalangos® ring was developed for pediatric annuloplasty to preserve the growth potential of the child's heart. It is also suitable for adult annuloplasty by extension. This now commercially available device made of biodegradable polydioxanone induces the growth of autologous fibrous tissue that reinforces the deficient annulus.

The good functioning of the native, or repaired valve depends on coaptation capacity of its leaflets. Annuloplasty rings have been used since 1968 to

Q. 2. Analyse the new concept at length in terms of Biodegradable principle.

Answer:Permanent metallic implants are key treatment options in cardiovascular interventions. However, specific drawbacks limit their more widespread use. These limitations include thrombogenicity, permanent physical irritation, mismatches in mechanical behaviour between stented and non-stented vessel areas, long term endothelial dysfunction, inability to adapt to growth, non-permissive or disadvantageous characteristics for later surgical revascularisation, and chronic inflammatory local reactions. Degradable implants offer more physiological repair, reconstitution of local vascular compliance, and a temporary, limited, longitudinal, and radial straightening effect, including the possibility for growth

Case -3

Bone Substitutes to replace Transplantation?

Points to be addressed

Q. 1. Outline the salient facts of the case.

Answer:Tumours, bone cysts and traumas, as well as osteomyelitis and osteolysis, can cause massive bone loss. The primary method used today for filling such defects is autogenic or allogeneic bone transplantation. As both approaches are associated with considerable problems there is an ongoing critical debate as to whether these procedures should still be considered the treatments of choice Autogenic bone transplantation, for instance, is always associated with another surgery.

Q. 2. Discuss at length on the line of the salient features.

Answer:Proper evaluation of the clinical success rates of tissueengineering techniques and products has been hampered by a lack of consistency in the experimental techniques used to induce periodontal defects among different animal groups for preclinical trials, as well as disparities in the methods used to analyze outcomes obtained by different technologies. The most popular animal models used for the assessment of periodontal regenerative protocols today involve ligature-induced periodontal defects in nonhuman primates (

Case -4

Eliminating Latent TB

Issues to be Addressed

Q. 1. List out the facts of the case.

Answer:A diagnosis of latent tuberculosis (LTB), also called latent tuberculosis infection (LTBI) means a patient is infected with Mycobacterium tuberculosis, but the patient does not have active tuberculosis. Active tuberculosis can be contagious while latent tuberculosis is not, and it is therefore not possible to get TB from someone with latent tuberculosis. The main risk is that approximately 10% of these patients (5% in the first two years after infection and 0.1% per year thereafter) will go on to develop active tuberculosis.

Q. 2. Project your perception on the new standard brought out in the testing.

Answer:The global health community has set itself the task of eliminating tuberculosis (TB) as a public health problem by 2050. Although progress has been made in global TB control, the current decline in incidence of 2% yr−1 is far from the rate needed to achieve this. If we are to succeed in this endeavour, new strategies to reduce the reservoir of latently infected persons (from which new cases arise) would be advantageous. However, ascertainment of the extent and risk posed by this group is poor. The current diagnostics tests (tuberculin skin test and interferon-gamma release assays) poorly predict who will develop active disease and

Q. 3. Analyse the case example provided.

Answer:Tuberculosis is recognized as the world's leading bacterial cause of death. Yet 95% of infection is believed to exist in an asymptomatic 'latent' form that is defined not by the identification of bacteria, but by the host immune response in the form of reactivity to tuberculosis proteins in the tuberculin skin test. It seems likely that clinically defined latent tuberculosis actually represents a spectrum that runs from elimination of live bacilli to subclinical disease: hence, it might be unhelpful to use a single term to describe all these conditions. To support this view, here we focus on recent increased understanding of the heterogeneity in both bacillary physiology and host immune response that potentially illuminates new therapeutic and

Case-5 --Gamma Knife Surgery – Saving Lives and Money?

Issues to Addressed

Q. 1. Identify the facts of the case.

Answer:

Q. 2. How would you consider this surgery as an innovative.

Answer:

Q. 3. What exactly is the recourse action the case tried to put forth in terms of saving life and money?

Answer:

Dear students get fully solved assignments

Send your semester & Specialization name to our mail id :

help.mbaassignments@gmail.com

or

call us at : 08263069601